Risk-Reducing Salpingo-Oophorectomy, Natural Menopause, and Breast Cancer Risk: An International Prospective Cohort of BRCA1 and BRCA2 Mutation Carriers

Breast Cancer Research - United Kingdom
doi 10.1186/s13058-020-1247-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Selected Features of Breast and Peritoneal Cancers Diagnosed in BRCA1 Carriers After Risk-Reducing Salpingo-Oophorectomy

Hereditary Cancer in Clinical Practice
OncologyGenetics
2019English

Uptake and Timing of Bilateral Prophylactic Salpingo-Oophorectomy Among BRCA1 and BRCA2 Mutation Carriers

Genetics in Medicine
MedicineGenetics
2008English

Plasma Osteoprotegerin and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Oncotarget
Oncology
2016English

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

JAMA - Journal of the American Medical Association
Medicine
2010English

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer

Cancers
Cancer ResearchOncology
2018English

Salpingo-Oophorectomy and the Risk of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women With a BRCA1 or BRCA2 Mutation

JAMA - Journal of the American Medical Association
Medicine
2006English

Body Weight and Risk of Breast Cancer in BRCA1/2 Mutation Carriers

Breast Cancer Research and Treatment
Cancer ResearchOncology
2010English

Risk Assessment for Hereditary Breast Cancer: BRCA1 and BRCA2

Canadian Oncology Nursing Journal
2010English

Cost Effectiveness of Bilateral Risk-Reducing Mastectomy and Salpingo-Oophorectomy

European Journal of Medical Research
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy